MUSC Rutledge Tower

💉VACCINE TRIAL: MUSC is one of 100 pediatric-centered sites across the world chosen to help with the Moderna pediatric trial. 15 children have participated in part one of the trial to find the appropriate dosing for children under 12. The next phase is vaccinating 105 children with the determined dose over the next 3 weeks. A MUSC doctor explained that although they are making progress, expected approval for the vaccine for those under 12 will most likely not happen until mid-winter.